Fei Xu

Henan University of Technology

Health Outcomes Studied

• Improved Gut Microbiota Composition
• Increased Immunoglobulin G Levels
• Reduced Uric Acid Levels

Papers (13)

• 2026
  Limosilactobacillus fermentum LF61: A multidimensional study on safety and functionality from genomics to clinical application.10.1016/j.fct.2026.116002
• 2026Primary author
  Recent Advances in Fluorinated Colloidal Nanosystems for Biological Detection and Surface Coating.10.3390/polym18030316
• 2026
  Sesquiterpenes from galangal essential oil as potent penetration enhancer: Effect on stratum corneum components and cutaneous TRPV4 ion channel.10.1016/j.xphs.2025.104134
• 2026
  Clinical Safety and Tolerability of <i>Bifidobacterium bifidum</i> BBi32: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial With Genomic and In Vitro Corroboration.10.1002/fsn3.71420
• 2026
  Gut microbiota and immune regulation by Lactobacillus delbrueckii subsp. bulgaricus LB42: From preclinical safety assessment to clinical evidence.10.1016/j.fct.2025.115851
• 2026
  Probiotic Supplementation With <i>Bifidobacterium longum</i> Subsp. <i>Longum</i> BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial.10.1002/fsn3.71437
• 2025
  A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults.10.1038/s41598-025-95208-2
• 2025Primary author
  Sustainable Emerging Proteins: Allergenic Proteins in Edible Insects, Microalgae, and Microorganisms, and Desensitization Processing Technologies.10.3390/foods15010069
• 2024
  Isoalantolactone: a review on its pharmacological effects.10.3389/fphar.2024.1453205
• 2024
  Extensive genomic characterization, pre-clinical probiotic evaluation, and safety analysis of Bifidobacterium longum subsp. longum BL21 isolated from infant feces.10.1016/j.micpath.2024.107100
• 2023
  Age-related hearing loss and its potential drug candidates: a systematic review.10.1186/s13020-023-00825-6
• 2023
  Changes in the gut microbiota composition of healthy young volunteers after administration of Lacticaseibacillus rhamnosus LRa05: A placebo-controlled study10.3389/fnut.2023.1105694
• 2019
  Recent Advances in the Pharmacological Activities of Dioscin.10.1155/2019/5763602